Journal of Cancer Research and Therapeutics: review time and acceptance speed

ISSN 0973-1482 · ISSN 1998-4138 · BioMed Central · Medicine

Half of the articles Journal of Cancer Research and Therapeutics accepted in 2024 were accepted within 171 days of submission (n = 135); the middle half took 112–258 days.

Submission → acceptance (2024)
171 days median
middle half 112–258 · n = 135
Acceptance → online
150 days median
middle half 87–225 · n = 136
Change since 2022
Slower than 2022: the median rose from 77 to 171 days (90% CI +73 to +115 days).
Open access · fees
Open access · no listed APC found

Accepted articles only · dates deposited by the publisher in PubMed · data as of Sep 15, 2026

Plan submissions to a deadline — free

How long does Journal of Cancer Research and Therapeutics take to accept a paper?

days0751502253002022: middle half 38–162 days772022n=2782023: middle half 61–211 days1122023n=1512024: middle half 112–258 days1712024n=135
Line = median; shaded box = middle half of articles (25th–75th percentile). Year of acceptance.
Days from submission to acceptance, by year of acceptance
YearArticles (n)25th pctMedian75th pct90th pctAccepted <14 daysHave a revised date
20241351121712581.5%0%
2023151611122111.3%0%
202227838771622756.1%0%

Distribution in 2024

0–29 days: 2% (3 articles)030–59 days: 9% (12 articles)3060–89 days: 4% (6 articles)6090–119 days: 15% (20 articles)90120–149 days: 10% (13 articles)120150–179 days: 15% (20 articles)150180–209 days: 9% (12 articles)180210–239 days: 4% (6 articles)210240–269 days: 10% (13 articles)240270–299 days: 7% (9 articles)270300–329 days: 1% (2 articles)300330–359 days: 4% (6 articles)330360+ days: 10% (13 articles)360+days from submission to acceptance (30-day bins)
Show as a table
DaysArticlesShare
0–2932.2%
30–59128.9%
60–8964.4%
90–1192014.8%
120–149139.6%
150–1792014.8%
180–209128.9%
210–23964.4%
240–269139.6%
270–29996.7%
300–32921.5%
330–35964.4%
360+139.6%

From acceptance to online publication

After acceptance, half of the 2024 articles appeared online within 150 days (middle half 87–225 days, n = 136).

From submission to online publication, the median was 356 days (middle half 267–488 days, n = 135).

Read these numbers carefully

  • These times describe articles the journal accepted. Rejected manuscripts never appear in public data, so they cannot tell you how long a rejection takes.
  • Dates are the ones the publisher deposited with PubMed. Some publishers record the date a revised manuscript arrived as the submission date, which makes review look faster.
  • Invited articles and special issues can move faster than regular submissions.

Open access status and publishing fees

Open access (not listed in DOAJ). No listed APC found in DOAJ or OpenAlex. That does not mean publishing is free — check the journal's author guidelines.

No institutional payments for this journal are recorded in OpenAPC.

Many journals waive or reduce fees for authors from eligible countries or institutions with publishing agreements — check with the journal and your library.

Integrity and indexing signals

Facts from public records, shown without judgement. See the methodology for why each can be worth a closer look.

Listed in DOAJNo
Articles indexed for MEDLINE in 2024Yes
Retractions1 retracted article among 1,789 added to PubMed in 2021–2025 (0.56 per 1,000), per the Retraction Watch Database.
Accepted within 14 days of submission1.5% of 2024 articles
Publication volume386 articles added to PubMed in 2024 (-15% vs 2023).

Topics and scope

Medicine journalsPulmonary and Respiratory Medicine journals

Similar journals — faster or cheaper, side by side

Journals publishing on the most similar topics (OpenAlex), ordered by similarity. Only 2024 figures are compared with the 2024 median of Journal of Cancer Research and Therapeutics, 171 days.

Paid APC medianDOAJMEDLINE
International Journal of Radiation Oncology*Biology*Physics153 (2024, n = 331)≈$4,130NoYes
Strahlentherapie und Onkologie112 (2024, n = 122)≈$4,390NoYes
Cancer/Radiothérapie43 (2024, n = 72)≈$2,190NoYes
Radiation Oncology135 (2024, n = 181)$3,290YesYes
Clinical and Translational Radiation Oncology97 (2024, n = 179)$2,530$1,549 (12 payments)YesNo
Clinical Oncology151 (2024, n = 144)≈$3,200NoYes
Radiology and Oncology76 (2024, n = 59)≈$1,731$1,544 (5 payments)YesYes
Reports of Practical Oncology & Radiotherapy173 (2024, n = 92)No fee (DOAJ)YesNo
Acta Oncologica117 (2024, n = 125)$2,440$2,283 (11 payments)YesYes

Frequently asked questions

How long does Journal of Cancer Research and Therapeutics take to accept a paper?

Half of the articles Journal of Cancer Research and Therapeutics accepted in 2024 were accepted within 171 days of submission (n = 135); the middle half took 112–258 days. Based on dates in PubMed for accepted articles only.

How long after acceptance are Journal of Cancer Research and Therapeutics articles published online?

Half of the articles accepted in 2024 appeared online within 150 days of acceptance (n = 136).

Does Journal of Cancer Research and Therapeutics charge an article processing charge (APC)?

No listed APC found in DOAJ or OpenAlex. That does not mean publishing is free — check the journal's author guidelines.

Sources and method

Journal identity: ISSN-L 0973-1482; NLM ID 101249598; OpenAlex record. Speed figures use 135 articles accepted in 2024 with valid dates; excluded records for that year: no received date 1.

Spotted a problem with this journal's data, or are you the publisher? Report a correction or email rafiq@gradsummit.com. Verified errors are corrected within five business days.

Get the free Journal Submission Go/No-Go Checklist

The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.

One email with your download, then occasional research tips. One-click unsubscribe, anytime. We never sell your data.

Get Write and Publish a Scientific Paper

Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.